28 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
Claims Act, which allows any individual to bring a lawsuit against a pharmaceutical company on behalf of the federal government alleging submission … . If the government decides to intervene and prevails in the lawsuit, the individual will share in the proceeds from any fines or settlement funds
F-3
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
in a statutory merger or demerger pursuant to the Swiss Merger Act can file an appraisal right lawsuit against the surviving company. As a result … . Nevertheless, certain actions may, to a limited extent, have a similar effect. An appraisal lawsuit won by a shareholder can be acted upon by any person
6-K
EX-99.1
OBSVF
ObsEva SA
22 Nov 22
Consent and Amendment Agreement
7:10am
”). The Company further agrees that it shall not commence, institute, or prosecute any lawsuit, action or other proceeding, whether judicial, administrative
6-K
EX-99.2
OBSVF
ObsEva SA
26 Oct 22
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of
5:11pm
”). Each Company Party further agrees that none of them shall commence, institute, or prosecute any lawsuit, action or other proceeding, whether
6-K
EX-99.2
OBSVF
ObsEva SA
1 Aug 22
ObsEva Announces $31 million Debt Retirement and $11 million Debt Refinancing
7:21am
, institute, or prosecute any lawsuit, action or other proceeding, whether judicial, administrative or otherwise, to prosecute, collect or enforce any
6-K
EX-99.2
2u1 773n1yn
27 May 22
ObsEva Announces Corporate Updates
4:56pm
6-K
EX-99.2
u8222edc
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K
EX-99.3
flqnzncq41m4
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K/A
EX-99.2
wyiowah2oatnn7
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
fpm1 s0syc
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
424B5
jzx8vdzv1avt
5 Mar 21
Prospectus supplement for primary offering
7:55am
424B5
l4e8cltkje57of9b70cj
8 Sep 20
Prospectus supplement for primary offering
7:31am
F-3
enttk0q07hfw0imxj7
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
zgk62d iudjwi
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
ckrwj9hk9p gcg
7 Aug 19
Current report (foreign)
7:21am